«RA Capital Management»
RA Capital Management
Non-Profits
Life sciences investment firm.
Invests into
Abcuro
Achilles Therapeutics
Agile Therapeutics
Akari Therapeutics
Arrowhead Pharmaceuticals
Artiva Biotherapeutics
Athersys
Be Biopharma
Bellicum Pharmaceuticals
Black Diamond Therapeutics
bluebird bio
Bright Peak Therapeutics
Bristol Myers Squibb
CellScape
Century Therapeutics
Collegium Pharmaceutical
Daloopa
Enara Bio
Everest Medicines
Expansion Therapeutics
EZOPS
Freenome
Frontier Medicines
Genelabs Technologies
Icosavax
Inozyme
Intarcia Therapeutics
ITeos Therapeutics
Legend Biotech
Metagenomi
Natera
Nimbus Therapeutics
Nkarta Therapeutics
Nucleix
Obsidian Therapeutics
Olema Oncology
Orchard Therapeutics
Ovascience
Pandion Therapeutics
Precision BioSciences
Sierra Oncology
Silverback Therapeutics
Sojournix
TScan Therapeutics
ViaCyte
Vor Biopharma
Wave Life Sciences
Zipline Medical
Technology:
Non-Profits
Industry:
Global Health Challenges
Register and Claim Ownership